Physician profile
Joan E Hader
NPI 1679583132
$1,992.90
in general payments reported to CMS, 2019-2025
26 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $113 · 2021: $293 · 2022: $318 · 2023: $174 · 2024: $303 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $653.29 | 2019-2025 | Xtandi |
| Medtronic, INC. | $213.55 | 2021-2025 | Interstim |
| Boston Scientific Corporation | $180.63 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Lithovue |
| Blue Earth Diagnostics | $152.03 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $123.69 | 2024-2025 | Gemtesa |
| C. R. Bard, INC. & Subsidiaries | $78.62 | 2022-2025 | Aptra |
| Abc Home Medical Supply, INC. | $75.72 | 2022-2023 | |
| Urovant Sciences INC | $59.52 | 2022 | |
| Coloplast Corp | $52.85 | 2019-2023 | Titan |
| Teleflex LLC | $52.73 | 2022-2024 | Urolift |
| Myriad Genetic Laboratories, INC. | $52.69 | 2024 | Prolaris |
| Abbvie INC. | $35.51 | 2020-2022 | |
| Olympus America INC. | $30.65 | 2024-2025 | Itind System |
| Innovation Technologies INC | $24.15 | 2025 | Irrisept |
| Civco Medical Instruments | $23.40 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $22.05 | 2025 | Cvac Aspiration System |
| Allergan, INC. | $19.97 | 2019 | |
| Karl Storz Endoscopy-America | $18.84 | 2023 | |
| Endo Pharmaceuticals INC. | $17.47 | 2023 | Xiaflex, Aveed |
| Tolmar, INC. | $17.16 | 2023 | |
| Profound Medical Corp. | $16.49 | 2025 | Tulsa-Pro |
| Ambu INC. | $16.15 | 2024 | |
| Zyla Life Sciences, INC. | $15.58 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.00 | 2024 | Adstiladrin |
| Travere Therapeutics, INC. | $13.95 | 2020-2021 | |
| Axonics, INC. | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Hader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.